Showing results (251-260 of 30,159) with videos related to

Sort By:
Pageof 3,016
Frontiers in Pharmacology|January 6, 2023
Combination of the parent analogue of remdesivir (GS-441524) and molnupiravir results in a markedly potent antiviral effect in SARS-CoV-2 infected Syrian hamstersRana Abdelnabi, Piet Maes, Steven de Jonghe, et al.
Frontiers in Pharmacology|January 6, 2023
An approach to data collection in compassionate use/managed accessSéverine Sarp, Ramona Reichenbach, Paul Aliu
Frontiers in Pharmacology|December 15, 2022
Pharmacokinetics of fluorobenzyl polyethylene glycol conjugated tetraiodothyroacetic acid (NP751), a novel anticancer thyrointegrin αvβ3 antagonistKazutoshi Fujioka, Bruce A Hay, Kavitha Godugu, et al.
Frontiers in Pharmacology|December 15, 2022
Ethnomedicinal, phytochemical and pharmacological investigations of Baccharis dracunculifolia DC. (ASTERACEAE)Zilda Cristiani Gazim, Juliana Silveira Valle, Isabela Carvalho Dos Santos, et al.
Frontiers in Pharmacology|December 15, 2022
Quantitative effects of sodium-glucose cotransporter-2 inhibitors dapagliflozin and empagliflozin on quality of life in heart failure patientsDong-Dong Wang, Cun Zhang, Ping Zhu, et al.
Frontiers in Pharmacology|December 16, 2022
Gallic acid suppresses the progression of triple-negative breast cancer HCC1806 cells via modulating PI3K/AKT/EGFR and MAPK signaling pathwaysSi Lin, Hui-Zhen Qin, Ze-Yu Li, et al.
Frontiers in Pharmacology|December 16, 2022
Targeting the chemerin/CMKLR1 axis by small molecule antagonist α-NETA mitigates endometriosis progressionMing Yu, Yali Yang, Hao Zhao, et al.
Frontiers in Pharmacology|December 16, 2022
Inhaled platelet vesicle-decoyed biomimetic nanoparticles attenuate inflammatory lung injuryHua Jin, Renxing Luo, Jianing Li, et al.
Frontiers in Pharmacology|December 16, 2022
Antiviral effects of the petroleum ether extract of Tournefortia sibirica L. against enterovirus 71 infection in vitro and in vivoXinyu Huang, Jiemin Li, Yan Hong, et al.
Frontiers in Pharmacology|December 16, 2022
LncRNA MEG3: Potential stock for precision treatment of cardiovascular diseasesZining Li, Jialiang Gao, Di Sun, et al.
Pageof 3,016